"GLP-1 treatment induces effective weight loss, but it also shifts the body into a chronic state of energy deficiency," said Professor Seon-ha Baek
The supplement stack for transition Certain supplements can support the transition off GLP-1 medications
As the trials progress, CagriSema could become a key player in the field of obesity treatment, offering a potent option for individuals struggling to lose weight
At the 3.0 mg daily dose, liraglutide produced average weight losses on the order of ~8% in pivotal trials (SCALE program), with additional benefits in glycemic measures and cardiometabolic risk markers
Some patients may continue medication long term, some may adjust the dose, and others may transition to a different maintenance plan
However, as briefly mentioned and for various reasons, data on statistical significance versus placebo were not obtained for all of the GLP-1RAs